Ronald P. Jordan & Philip Schneider

Jul 22, 2026

Promising Science Should Encourage More Research

The FDA’s upcoming Pharmacy Compounding Advisory Committee meeting on unapproved peptides is about more than a handful of substances under review. At stake is whether our...